Bookmark and Share

Last Minute:          For more news, click here.

Remember me? 

Show More News:
 Watch more news

News search related to the stock ADC Telecommunica (ordered by date):

  1. ADC Therapeutics SA (ADCT) CEO Ameet Mallik on Q2 2022 Results - Earnings Call Transcript  Seeking Alpha
  2. ADC Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates  Business Wire
  3. ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates  Nasdaq
  4. Adc Therapeutics Sa Down 1.37% To $7.94 After Earnings Beat  InvestorsObserver
  5. ADC Therapeutics (ADCT) Set to Announce Quarterly Earnings on Tuesday  Defense World
ADC Therapeutics SA Tops Q2 EPS by 7c By UK ADC Therapeutics Doses First Patient in Phase 1b Clinical Trial of ADCT-601 Targeting AXL as a Single Agent and in Combination with Gemcitabine in Advanced Solid Tumors  Business Wire Prospera Financial Services Inc Purchases Shares of 5921 ADC Therapeutics SA (NYSE:ADCT)  Defense World Overland ADCT BioPharma Announces First Patient Dosed in China with ZYNLONTAŽ in Combination with Rituximab in Global Phase 3 Clinical Trial  Business Wire 2022-08-02 | NYSE:ADCT | Press Release | ADC Therapeutics SA  Stockhouse ADC Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of ZYNLONTAŽ (loncastuximab tesirine-lpyl) in Combination with Rituximab in First-Line Diffuse Large B-Cell Lymphoma  Business Wire ADC Therapeutics to Host Second Quarter 2022 Financial Results Conference Call on August 9, 2022  Valdosta Daily Times ADC India Communications standalone net profit rises 18.18% in the June 2022 quarter  Business Standard DNA sequence-selective G-A cross-linking ADC payloads for use in solid tumour therapies | Communications Biology Moderna (MRNA) to Report Q2 Earnings: What's in the Cards?  Nasdaq At a CAGR of 19.1% Application Delivery Controllers (ADC) Market Size to Garner $12.8 billion by 2030  EIN News Intercept Pharmaceuticals (ICPT) Reports Q2 Loss, Misses Revenue Estimates  Nasdaq ADC Therapeutics SA (ADCT) Q1 2022 Earnings Call Transcript  The Motley Fool Mobile Internet services restored in Manipur; economic blockade to continue  Economic Times Mobile and Wireless Backhaul Equipment Market ? Major Technology Giants in Buzz Again | ADC Telecommunica...  This Is Ardee Sobi to license loncastuximab tesirine from ADC Therapeutics  Sobi T1 Gumayusi scores a pentakill in final Telecom War of 2022  ONE Esports SEC Analysis and Detection Center Identifies Suspicious Trading  The National Law Review FDA Accepts Byondis' Biologics License Application for [Vic-] Trastuzumab Duocarmazine (SYD985) in HER2-Positive Metastatic Breast Cancer  PR Newswire Liquid Cloud announces access to Oracle Cloud via FastConnect  TelecomTV PLDT expands international data capacity ADC Therapeutics to Present at the BofA Securities 2022 Healthcare Conference  Business Wire Centene (CNC) Gears Up for Q2 Earnings: What Lies Ahead?  Nasdaq ADC Therapeutics Announces Abstracts to be Presented at the European Hematology Association 2022 Hybrid Congress  Business Wire ADC Therapeutics Releases its Inaugural Environmental, Social and Governance Report  Business Wire ADC Therapeutics Names David Gilman as Chief Business & Strategy Officer  Business Wire Analog To Digital Converter Market to Grow with a Significant CAGR During the forecast period 2022-2028| Exclusive Report Spread Across 109 Pages  Digital Journal ADC Therapeutics to Host First Quarter 2022 Financial Results Conference Call on May 9, 2022  Yahoo Finance ADC Therapeutics Appoints Jean-Pierre Bizzari, MD, to Board of Directors  Business Wire ADC Therapeutics begins dosing in study of Zynlonta combo for blood cancer subtype  Seeking Alpha ADC Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates  Yahoo Finance PTAB Weighs Printed Publication Fight In Wireless Tech Case  Law360 ADC Therapeutics Doses First Patient in Phase 1 Clinical Trial of ADCT-901 in Advanced Solid Tumors  Business Wire Application Delivery Controllers (ADCs) Market Size, Comprehensive Analysis, Development Strategy, Future Plans and Industry Growth with High CAGR by Forecast 2028 | COVID-19 Impact ? Shanghaiist  Shanghaiist Elevation Oncology Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress  PR Newswire ADC Therapeutics Announces Results from Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine (Cami) in Relapsed or Refractory Hodgkin Lymphoma  Business Wire Court Hears Suit To Sack Tonto Dikeh, Tonte Ibraye As ADC Candidates  InfoGuide Nigeria ADC Therapeutics to Present at the Jefferies Healthcare Conference  Business Wire ADC Therapeutics Receives Permanent J-Code for ZYNLONTAŽ (J9359) from U.S. Centers for Medicare & Medicaid Services  Business Wire Owkin, ADC Therapeutics Team on AI-Based Biomarker Discovery  GenomeWeb ADC Therapeutics Enters Into a Financing Agreement with HealthCare Royalty for Up to $325 Million  Business Wire The Global Current Sensor Market Future Plans and Growth with Quantitative And Qualitative Analysis at CAGR of 10.8%  Digital Journal ADC Therapeutics Announces Validation of its Marketing Authorization Application by the European Medicines Agency for ZYNLONTAŽ  Yahoo Finance Kachikwu to NASS members: Impeach your leaders before Buhari  Blueprint Newspapers Limited Agree Realty Corporation Reports Second Quarter 2022 Results  PR Newswire ADC Therapeutics : CEO Letter to Shareholders - Form 6-K Innovent Biologics and Sanofi Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China  PR Newswire ADC Therapeutics and Overland Pharmaceuticals Announce Formation of Overland ADCT BioPharma to Develop and Commercialize Lonca and other ADCs for Hematologic and Solid Tumor Indications in Greater China and Singapore  Business Wire ADC Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates  Business Wire ADC Therapeutics : Overland ADCT BioPharma Announces First Patient Dosed in China with ZYNLONTAŽ in Combination with Rituximab in Global Phase 3 Clinical Trial - Form 6-K Permanent J-code for ADC Therapeutics' Zynlonta  The Pharma Letter ADCT Awaits Cami Trial Data, CSTL Boosts Revenue Outlook, ANNX To Report HD Trial Data In Q2  Nasdaq The top 10 antibody-drug conjugate contenders in 2021  FiercePharma Bergenbio dream lives on, despite Genmab's broken Axl  Evaluate Pharma ADCT Exercises Option to License Chiome's Anti-DLK-1 mAb for ADC Development  Genetic Engineering & Biotechnology News ADC Therapeutics to develop anti-cancer drugs in new White City Campus centre  Imperial College London ADC Therapeutics Announces Encouraging Interim Results from Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine (Cami) Presented at the 16th Annual International Conference on Malignant Lymphoma  Business Wire ADC Therapeutics and Overland Pharma Form Strategic JV to Expand ADC Drugs Development and commercialization in Greater China and Singapore, Advised by MSQ Ventures  PR Newswire Overland ADCT BioPharma Appoints Eric Koo as Chief Executive Officer  Business Wire Virtual Data Room Market 2022 Is Expected to reach CAGR 15.12% till 2027 |Top Companies, Huge Growth in Future and Forecast  Digital Journal Understanding Interface Analog-to-Digital Converters (ADCs) with DataStorm DAQ FPGA  Design and Reuse AstraZeneca helps ADCT to $200M megaround to push anticancer ADCs to pivotal data  FierceBiotech ADC Therapeutics Announces FDA Approval of ZYNLONTA? (loncastuximab tesirine-lpyl) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma  Business Wire ADC Therapeutics Announces Pricing of Upsized Initial Public Offering  GlobeNewswire Application Delivery Controllers (ADC) Market to Reach $12.8 Bn, Globally, by 2030 at 19.1% CAGR: Allied Market Research  PR Newswire Kyowa Kirin Expands License Agreement with Synaffix and Takes Exclusive Target Rights Based on Latest Positive ADC Data  PR Newswire ProfoundBio Announces Completion of $70 Million Series A+ Financing to Advance Antibody-Drug Conjugate (ADC) Programs into the Clinic  PR Newswire Africa Data Centres to increase capacity in Johannesburg, South Africa to 100MW  DatacenterDynamics Coming together for Zynlonta  Cancer Research UK News ADCT Stock Forecast, Price & News (ADC Therapeutics)  MarketBeat ADC Therapeutics Presents Updated ZYNLONTA? (loncastuximab tesirine-lpyl) Clinical Data at 16th Annual International Conference on Malignant Lymphoma  Business Wire Byondis and medac Enter Into License and Collaboration and Supply Agreements for Anti-HER2 ADC Trastuzumab Duocarmazine (SYD985)  PR Newswire UK ADC Therapeutics: Q2 Earnings Insights  Benzinga ADC Therapeutics Announces a $115 Million Convertible Credit Facility with Deerfield  GlobeNewswire Genmab and Synaffix Enter into License Agreement for ADC Technology  PR Newswire MICROSOFT AFRICA DEVELOPMENT CENTER (ADC) CONNECTS DEVELOPERS THROUGH ITS USER GROUP SERIES, AZURE DEVELOPERS CONNECT  PR Newswire UK Microsoft Africa Development Center (ADC) West Africa inspires schoolgirls on the International Girls in ICT Day 2022  Techpoint Africa Africa Data Centres announces two facilities in Nairobi, Kenya  DatacenterDynamics People's Republic of China State-Sponsored Cyber Actors Exploit Network Providers and Devices | CISA  US-CERT Manipur ADC bill row: Tribal students call for shutdown yet again in hill districts  The Indian Express Synaffix and Mersana add license options for six ADC targets to existing deal  The Pharma Letter Watch | Manipur ADC Bill 2021: 'Democratic Aspirations of Hill Areas Must Be Respected'  The Wire Bishop Onuoha set to declare for Abia governorship as ADC decries money politics  Vanguard ADC Acquisition Corporation to open IPO subscription on May 12  ZAWYA Liquid's ADC to build 'biggest African data centre' outside South Africa  Capacity Media 2023: Moghalu dumps ADC after losing presidential ticket  Daily Post Nigeria The European, Middle East and African Antitrust Review  Global Competition Review ADC Therapeutics (NYSE:ADCT) Has Debt But No Earnings; Should You Worry?  Yahoo Eurosport UK ADC Therapeutics Begins U.S. IPO Process (NYSE:ADCT)  Seeking Alpha Oxford BioTherapeutics Announces Research Collaboration with ImmunoGen to Develop Novel Antibody-Drug Conjugates  PR Newswire UK Global Cancer Antibody Drug Conjugates Industry, 2022-2028 - A $25B+ Opportunity Assessment with Daiichi Sankyo, Roche, Gilead Sciences, ADC Therapeutics, AstraZenca, and Seagen Dominating  PR Newswire Fitch Affirms Liquid Telecom at 'B+'; Outlook Stable  Fitch Ratings ADC Therapeutics and Freenome Enter Biomarker Development Collaboration  GlobeNewswire ADC Acquisition Corporation shares to start trading on ADX from Friday 27 May  ZAWYA Current Affairs 12 July 2022 ProfoundBio to Highlight Programs and Technology at AACR 2022 Annual Meeting; Welcomes Zhu Chen, PhD, as Chief Scientific Officer  PR Newswire Asia Direct Cable Has Landed in Vietnam  SubTel Forum Viettel to build new data center in Ho Chi Minh City, Vietnam  DatacenterDynamics BiOneCure Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for BIO-106, a Novel TROP2 ADC for the Treatment of Advanced Solid Tumors  PR Newswire
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2022 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources